Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.0290
-0.0020 (-6.45%)
May 5, 2026, 3:56 PM EST
Bioxytran Market Cap
Bioxytran has a market cap or net worth of $3.29 million as of May 6, 2026. Its market cap has decreased by -79.38% in one year.
Market Cap
3.29M
Enterprise Value
4.07M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since September 24, 2018, Bioxytran's market cap has decreased from 25.52M to 3.29M, a decrease of -87.12%. That is a compound annual growth rate of -23.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 3.29M | -59.67% |
| Dec 31, 2025 | 8.15M | 4.49% |
| Dec 31, 2024 | 7.80M | -64.29% |
| Dec 29, 2023 | 21.85M | -63.00% |
| Dec 30, 2022 | 59.05M | 33.18% |
| Dec 31, 2021 | 44.34M | 89.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mosaic ImmunoEngineering | 5.40M |
| AccuStem Sciences | 4.50M |
| GPL Holdings | 4.17M |
| Institute of Biomedical Research | 4.12M |
| Orgenesis | 3.92M |
| CASI Pharmaceuticals | 2.86M |
| Oncology Pharma | 2.71M |
| Vaccinex | 2.70M |